MyFinsight
Home
Blog
About
Proceeds from maturities
of investment...
$27,500K
(-82.17%↓ Y/Y)
Issuance of common stock
through employee stock...
$464K
(28.53%↑ Y/Y)
Proceeds from the
exercise of stock options
$141K
(513.04%↑ Y/Y)
Net cash provided by
investing activities
$15,056K
(-46.20%↓ Y/Y)
Net cash provided by
financing activities
$605K
(57.55%↑ Y/Y)
Canceled cashflow
$12,444K
Net decrease in cash
and cash...
$137K
(104.79%↑ Y/Y)
Canceled cashflow
$15,524K
Purchases of investment
securities
$12,423K
(-90.15%↓ Y/Y)
Purchases of property and
equipment
$21K
(-86.79%↓ Y/Y)
Stock-based compensation
$3,867K
(-48.60%↓ Y/Y)
Accounts payable and
other liabilities
$955K
(296.27%↑ Y/Y)
Depreciation
$151K
(-51.45%↓ Y/Y)
Non-cash lease expense
$74K
(1333.33%↑ Y/Y)
Net cash used in
operating activities
-$15,524K
(50.29%↑ Y/Y)
Canceled cashflow
$5,047K
Net loss
-$20,165K
(45.20%↑ Y/Y)
Prepaid expense and
other assets
$391K
(-59.06%↓ Y/Y)
Amortization of premiums on
investment securities, net
$15K
(-99.24%↓ Y/Y)
Back
Back
Cash Flow
Design Therapeutics, Inc. (DSGN)
Design Therapeutics, Inc. (DSGN)
source: myfinsight.com